Katrina A. B. Goddard
#170,069
Most Influential Person Now
American genetic epidemiologist and biostatistician
Katrina A. B. Goddard's AcademicInfluence.com Rankings
Katrina A. B. Goddardmedical Degrees
Medical
#3682
World Rank
#4178
Historical Rank
Epidemiology
#808
World Rank
#843
Historical Rank
Katrina A. B. Goddardmathematics Degrees
Mathematics
#8334
World Rank
#11327
Historical Rank
Statistics
#1222
World Rank
#1334
Historical Rank
Download Badge
Medical Mathematics
Katrina A. B. Goddard's Degrees
- Bachelors Biology University of California, Berkeley
- PhD Biostatistics Stanford University
Similar Degrees You Can Earn
Why Is Katrina A. B. Goddard Influential?
(Suggest an Edit or Addition)According to Wikipedia, Katrina A. Blouke Goddard is an American genetic epidemiologist and biostatistician specializing in public health genomics and the translation of genomic applications into clinical practice. Goddard is the director of the division of cancer control and population sciences at the National Cancer Institute . She was previously the distinguished investigator and director of translational and applied genomics at the Kaiser Permanente Center for Health Research and a faculty member at Case Western Reserve University.
Katrina A. B. Goddard's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study (2012) (483)
- Genetic modifiers of lung disease in cystic fibrosis. (2005) (475)
- Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations. (2000) (222)
- Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2 (2011) (221)
- Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4. (2001) (180)
- Improving reporting standards for polygenic scores in risk prediction studies (2020) (175)
- Genomewide scan for prostate cancer-aggressiveness loci. (2000) (158)
- A genome screen of multiplex sibships with prostate cancer. (2000) (157)
- Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. (2011) (152)
- Genome-Wide Scans for Diabetic Nephropathy and Albuminuria in Multiethnic Populations (2007) (148)
- Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. (2016) (143)
- Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. (2005) (119)
- Transforming Epidemiology for 21st Century Medicine and Public Health (2013) (116)
- Candidate-Gene Association Study of Mothers with Pre-Eclampsia, and Their Infants, Analyzing 775 SNPs in 190 Genes (2006) (114)
- Family history and the natural history of colorectal cancer: systematic review (2015) (112)
- Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study (2018) (107)
- Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy (2015) (91)
- The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations. (2018) (91)
- Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group. (2013) (90)
- The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. (1994) (90)
- A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. (2002) (87)
- Cost-effectiveness analysis of screening for KRAS and BRAF mutations in metastatic colorectal cancer. (2012) (86)
- Influence of apolipoprotein E genotype on the transmission of Alzheimer disease in a community-based sample. (1996) (83)
- The evolving landscape of expanded carrier screening: challenges and opportunities (2018) (77)
- Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population (2008) (77)
- Segregation analysis of phenotypic components of learning disabilities. I. Nonword memory and digit span. (2000) (75)
- A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation (2016) (74)
- Modulation of cystic fibrosis lung disease by variants in interleukin-8 (2008) (71)
- The amyloid precursor protein locus and very-late-onset Alzheimer disease. (2001) (64)
- Chromosome 14 and late-onset familial Alzheimer disease (FAD). (1993) (61)
- Genome-Wide Scan for Estimated Glomerular Filtration Rate in Multi-Ethnic Diabetic Populations (2008) (61)
- A survey of current practices for genomic sequencing test interpretation and reporting processes in US laboratories (2016) (61)
- Awareness and use of direct-to-consumer nutrigenomic tests, United States, 2006 (2007) (58)
- Schistosomal hepatic fibrosis and the interferon gamma receptor: a linkage analysis using single-nucleotide polymorphic markers (2005) (58)
- Health-Related Direct-to-Consumer Genetic Tests: A Public Health Assessment and Analysis of Practices Related to Internet-Based Tests for Risk of Thrombosis (2008) (56)
- Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population. (2005) (55)
- Dengue hemorrhagic fever is associated with polymorphisms in JAK1 (2010) (51)
- Genomewide Linkage Scan for Diabetic Renal Failure and Albuminuria: The FIND Study (2011) (49)
- “Is It Worth Knowing?” Focus Group Participants’ Perceived Utility of Genomic Preconception Carrier Screening (2015) (49)
- Public awareness and use of direct-to-consumer genetic tests: results from 3 state population-based surveys, 2006. (2009) (48)
- Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies (2013) (46)
- Toward localization of the Werner syndrome gene by linkage disequilibrium and ancestral haplotyping: lessons learned from analysis of 35 chromosome 8p11.1-21.1 markers. (1996) (46)
- Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer (2013) (46)
- Stakeholder perspectives on implementing a universal lynch syndrome screening program: A qualitative study of early barriers and facilitators (2015) (41)
- Barriers in Identification and Referral to Genetic Counseling for Familial Cancer Risk: The Perspective of Genetic Service Providers (2011) (41)
- Biobank Recruitment: Motivations for Nonparticipation. (2009) (38)
- HER2 Evaluation and Its Impact on Breast Cancer Treatment Decisions (2011) (37)
- EDNRA variants associate with smooth muscle mRNA levels, cell proliferation rates, and cystic fibrosis pulmonary disease severity. (2010) (36)
- Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research (2012) (36)
- Analytical approaches to detect maternal/fetal genotype incompatibilities that increase risk of pre-eclampsia (2008) (36)
- Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects. (2013) (35)
- Reasons for Declining Preconception Expanded Carrier Screening Using Genome Sequencing (2017) (34)
- Association of Kallikrein Gene Polymorphisms With Intracranial Aneurysms (2007) (32)
- Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease (2004) (32)
- Preconception Carrier Screening by Genome Sequencing: Results from the Clinical Laboratory. (2018) (31)
- Universal tumor screening for Lynch syndrome: Assessment of the perspectives of patients with colorectal cancer regarding benefits and barriers (2015) (31)
- Returning negative results to individuals in a genomic screening program: Lessons learned (2018) (30)
- Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential (2019) (30)
- Evidence‐based assessments of clinical actionability in the context of secondary findings: Updates from ClinGen's Actionability Working Group (2018) (29)
- Design of a randomized controlled trial for genomic carrier screening in healthy patients seeking preconception genetic testing (2016) (28)
- Linkage disequilibrium and haplotype studies of chromosome 8p 11.1-21.1 markers and Werner syndrome. (1994) (28)
- Generating a taxonomy for genetic conditions relevant to reproductive planning (2016) (27)
- The Genomic Medicine Integrative Research Framework: A Conceptual Framework for Conducting Genomic Medicine Research. (2019) (25)
- Evidence for association between the HLA-DQA locus and abdominal aortic aneurysms in the Belgian population: a case control study (2006) (25)
- A Genome-Wide Search for Linkage of Estimated Glomerular Filtration Rate (eGFR) in the Family Investigation of Nephropathy and Diabetes (FIND) (2013) (25)
- Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies (2012) (24)
- Cost Effectiveness of Age-Specific Screening Intervals for People With Family Histories of Colorectal Cancer. (2018) (23)
- Time Costs for Genetic Counseling in Preconception Carrier Screening with Genome Sequencing (2018) (23)
- KRAS Testing and Epidermal Growth Factor Receptor Inhibitor Treatment for Colorectal Cancer in Community Settings (2012) (23)
- Patients' ratings of genetic conditions validate a taxonomy to simplify decisions about preconception carrier screening via genome sequencing (2016) (22)
- Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing (2017) (22)
- Leveraging biospecimen resources for discovery or validation of markers for early cancer detection. (2015) (21)
- Estimating haplotype frequencies in pooled DNA samples when there is genotyping error (2005) (21)
- The NextGen Study: patient motivation for participation in genome sequencing for carrier status (2017) (20)
- Validity of Eight Integrated Healthcare Delivery Organizations' Administrative Clinical Data to Capture Breast Cancer Chemotherapy Exposure (2012) (19)
- Assessment of willingness to pay for expanded carrier screening among women and couples undergoing preconception carrier screening (2018) (19)
- Patient perspectives on the use of categories of conditions for decision making about genomic carrier screening results (2018) (19)
- Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews (2018) (18)
- Beta 2 adrenergic receptor polymorphisms in cystic fibrosis (2005) (18)
- It’s complicated: criteria for policy decisions for the clinical integration of genome-scale sequencing for reproductive decision making (2015) (18)
- Practical Barriers and Ethical Challenges in Genetic Data Sharing (2014) (18)
- Evidence synthesis and guideline development in genomic medicine: current status and future prospects (2014) (17)
- Erratum: Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine (American Journal of Human Genetics (2016) 98(6) (1067–1076) (S0002929716301069) (10.1016/j.ajhg.2016.04.011)) (2016) (17)
- Fecal DNA Testing in Screening for Colorectal Cancer in Average-Risk Adults (2012) (16)
- Evaluating genomic tests from bench to bedside: a practical framework (2012) (16)
- Utilization of HER2 genetic testing in a multi-institutional observational study. (2012) (15)
- Patient actions and reactions after receiving negative results from expanded carrier screening (2018) (14)
- Online Education and e-Consent for GeneScreen, a Preventive Genomic Screening Study (2017) (14)
- Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives (2017) (13)
- Oncologists' attitudes toward KRAS testing: a multisite study (2013) (13)
- Approaches to carrier testing and results disclosure in translational genomics research: The clinical sequencing exploratory research consortium experience (2018) (13)
- Development and early implementation of an Accessible, Relational, Inclusive and Actionable approach to genetic counseling: The ARIA model. (2020) (13)
- Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations. (2021) (12)
- Genome‐wide linkage scans for type 2 diabetes mellitus in four ethnically diverse populations—significant evidence for linkage on chromosome 4q in African Americans: the Family Investigation of Nephropathy and Diabetes Research Group (2009) (12)
- Lessons Learned From A Study Of Genomics-Based Carrier Screening For Reproductive Decision Making. (2018) (11)
- Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings (2018) (11)
- Approaches to integrating germline and tumor genomic data in cancer research. (2014) (11)
- Integrating stakeholder feedback in translational genomics research: An ethnographic analysis of a study protocol’s evolution (2020) (10)
- Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study (2019) (9)
- Genetic Analysis Workshop 15: gene expression analysis and approaches to detecting multiple functional loci (2007) (9)
- Interaction of gender and body mass index (BMI) reveals evidence of linkage for hypertension in the Framingham Heart Study (2003) (9)
- Linkage analysis of alcoholism-related electrophysiological phenotypes: genome scans with microsatellites compared to single-nucleotide polymorphisms (2005) (8)
- Demonstrating ‘respect for persons’ in clinical research: findings from qualitative interviews with diverse genomics research participants (2020) (8)
- Lessons learned about harmonizing survey measures for the CSER consortium (2020) (8)
- Density-based clustering in haplotype analysis for association mapping (2007) (7)
- Does KRAS Testing in Metastatic Colorectal Cancer Impact Overall Survival? A Comparative Effectiveness Study in a Population-Based Sample (2014) (7)
- Participant Reactions to a Literacy-Focused, Web-Based Informed Consent Approach for a Genomic Implementation Study (2020) (7)
- Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine. (2016) (7)
- Identification of nephropathy candidate genes by comparing sclerosis-prone and sclerosis-resistant mouse strain kidney transcriptomes (2012) (7)
- HLA–DQA Is Associated with Abdominal Aortic Aneurysms in the Belgian Population (2006) (6)
- A decision aid for additional findings in genomic sequencing: Development and pilot testing. (2020) (6)
- Assessing the implications of positive genomic screening results (2020) (5)
- Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories (2012) (5)
- Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population (2021) (5)
- Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system (2022) (5)
- PS1-08: Lynch Syndrome Screening Patterns in Colorectal Cancer Patients in a Large Multi-institutional Cohort (2012) (4)
- Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities. (2021) (4)
- Effect of genotyping error in model-free linkage analysis using microsatellite or single-nucleotide polymorphism marker maps (2005) (4)
- Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting (2019) (4)
- Prediction of Empirical p Values from Asymptotic p Values for Conditional Logistic Affected Relative Pair Linkage Analysis (2006) (4)
- Genetic predisposition for preterm PROM: Results of a large candidate-gene association study of mothers and their offspring (2005) (4)
- Using Overall Allele-Sharing to Detect the Presence of Large-Scale Data Errors and Parameter Misspecification in Sib-Pair Linkage Studies (2004) (3)
- Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access. (2022) (3)
- Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study (2019) (3)
- Universal screening for Lynch syndrome among patients with colorectal cancer: patient perspectives on screening and sharing results with at-risk relatives (2017) (2)
- Establishing the Medical Actionability of Genomic Variants. (2022) (2)
- PS2-11: Validation of KRAS Mutation Testing Across Five Certified Laboratories (2011) (2)
- Expert and lay perspectives on burden, risk, tolerability, and acceptability of clinical interventions for genetic disorders (2019) (2)
- Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system (2022) (2)
- Barriers to family history knowledge and family communication among LGBTQ+ individuals in the context of hereditary cancer risk assessment (2021) (1)
- PS1-11: Specimen Collection Within the Cancer Research Network: A Critical Appraisal (2010) (1)
- Engaging Patient Advisory Committees to Inform a Genomic Cancer Risk Study: Lessons for Future Efforts. (2022) (1)
- An accessible, relational, inclusive, and actionable (ARIA) model of genetic counseling compared with usual care: Results of a randomized controlled trial. (2022) (1)
- Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews (2022) (1)
- The PrU: development and validation of a measure to assess personal utility of genomic results. (2022) (1)
- Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories (2012) (1)
- Risk‐reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system (2022) (1)
- C-C1-02: Validity of HMO Administrative Data for Breast Cancer Chemotherapy Exposure (2011) (1)
- Barriers to knowledge of family history and family communication among LGBTQ+ individuals in the context of hereditary cancer risk assessment (2021) (0)
- Recommended care and care adherence following a diagnosis of Lynch syndrome: a mixed-methods study (2019) (0)
- The Kaiser Permanente Biobank: A Multiregion Resource Linking Specimens and Electronic Medical Records for Broad Research in an Integrated Health Care Delivery System (2015) (0)
- Motivations and Concerns of Patients Considering Participation in an Implementation Study of a Hereditary Cancer Risk Assessment Program in Diverse Primary Care Settings (2021) (0)
- CB2-05: Chemotherapy Treatment Patterns Among Advanced Colon Cancer Patients (2012) (0)
- Corrigendum to "Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations" [Contemporary Clinical Trials 106 (2021) 106432]. (2022) (0)
- Jane M. Olson (December 6, 1952–May 2, 2004) (2004) (0)
- PS2-31: Implementation of Universal Lynch Syndrome Screening in an Integrated Health Care Delivery System (2013) (0)
- Returning negative results to individuals in a genomic screening program: lessons learned (2018) (0)
- Discordant Patient and Clinician Perspectives on the Potential Value of Genetic Services in Safety-Net Clinics (2020) (0)
- A case for expanding carrier testing to include actionable X‐linked disorders (2018) (0)
- Integrating stakeholder feedback in translational genomics research: an ethnographic analysis of a study protocol’s evolution (2020) (0)
- Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy (2015) (0)
- absence of the vas deferens and their association with cystic fibrosis genetic modifiers Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital (2015) (0)
- Implementation of a Systematic Tumor Screening Program for Lynch Syndrome in an Integrated Health Care Setting (2019) (0)
- ClinGen’s actionability working groups: development and early implementation of an assertion rubric for clinical actionability (2021) (0)
- Evaluating cancer genetic services in a safety net system: overcoming barriers for a lasting impact beyond the CHARM research project. (2023) (0)
- ClinGen curation tools, web services and repository for clinical actionability assertions and supporting evidence (2021) (0)
- Clinical actionability of secondary findings in the pediatric context (2021) (0)
- Cancer Epidemiology in the 21 st Century Transforming Epidemiology for 21 st Century Medicine and Public Health (2013) (0)
- PS1-08: Genetic Service Providers Identify Barriers Related to Referral, Counseling and Testing for Familial Cancer (2010) (0)
- Abstract P1-08-02: CYP2D6 gene variants and effectiveness of adjuvant tamoxifen in breast cancer: A population-based case-control study (2016) (0)
- ClinGen's Pediatric Actionability Working Group: Clinical actionability of secondary findings from genome-scale sequencing in children and adolescents. (2022) (0)
- Literacy-adapted, electronic family history assessment for genetics referral in primary care: patient user insights from qualitative interviews (2022) (0)
- Universal Screen for Lynch Syndrome in an Integrated Health Care System: Assessment of Patient Perspectives and Sharing Results With At-Risk Relatives (2016) (0)
- Abstract PO-050: Reducing disparities in genomic medicine using a literacy-focused genetic counseling model for cancer risk assessment (2020) (0)
- Impact of expanded carrier screening on health care utilization. (2021) (0)
- PS1-14: Utilization and Effectiveness of KRAS Testing for Colorectal Cancer (2010) (0)
- Evidence for HLA-DQA1 locus being associated with abdominal aortic aneurysms in the Belgian population (2005) (0)
- P270: Characterizing clinical actionability in the context of polygenic risk assessment* (2023) (0)
- Successful recruitment of medically underserved populations into genetic studies: lessons learned from the CHARM study (2021) (0)
- Correction: Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study (2019) (0)
- Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study (2018) (0)
- ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial. (2022) (0)
- Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system (2022) (0)
- Anticipated responses of early adopter genetic specialists and nongenetic specialists to unsolicited genomic secondary findings (2018) (0)
- Qualitative assessment of a patient-facing hereditary cancer risk assessment tool: barriers and solutions (2021) (0)
- Developing an algorithm across integrated healthcare systems to identify a history of cancer using electronic medical records (2022) (0)
- Erratum: Stakeholder assessment of the evidence for cancer genomic tests: Insights from three case studies (Genetics in Medicine (2012) 14 (656-662) DOI: 10.1038/gim.2012.3) (2013) (0)
- Patient and provider perspectives on adherence to and care coordination of lynch syndrome surveillance recommendations: findings from qualitative interviews (2018) (0)
- Abstract PR02: Using web-based tools to assess familial cancer risk in diverse populations (2020) (0)
- CORRIGENDUM: Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies (2013) (0)
- P1-280 Novel polymorphism in lipoprotein receptor-related protein 1 (LRP1) shows significant association with Alzheimer’s disease (2006) (0)
- Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system (2022) (0)
- Expert and lay perspectives on burden, risk, tolerability, and acceptability of clinical interventions for genetic disorders (2019) (0)
This paper list is powered by the following services:
Other Resources About Katrina A. B. Goddard
What Schools Are Affiliated With Katrina A. B. Goddard?
Katrina A. B. Goddard is affiliated with the following schools:
